BioSpace News Archive

Biotech Bay

AltruBio to Participate in Upcoming May 2024 Medical Conferences

AltruBio Inc. today announced that management will participate in the following May 2024 medical conferences.

May 1, 2024
·
3 min read
Business

Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time to report financial results for the first quarter 2024 and to highlight recent corporate progress.

May 1, 2024
·
1 min read
Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USA

Poolbeg Pharma announces that, further to its announcement on20 March 2024,the Company has received the fully granted patent from the US Patent Office for its Immunomodulator II patent application.

May 1, 2024
·
5 min read
Drug Development

MindBio Is Exploring Dual Listing on A Senior Exchange with Multiple Phase 2B Clinical Trials Underway Supported by Positive Trial Data and Planning for Phase 3

MindBio Therapeutics Corp. is pleased to announce that it has been presenting MindBio to various parties, institutional investment firms and brokerage firms for a potential dual listing on a senior exchange in the United States or Australia.

May 1, 2024
·
5 min read
Business

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024

Iovance Biotherapeutics, Inc., a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte therapies for patients with cancer, will report its first quarter 2024 financial results on Thursday, May 9, 2024.

May 1, 2024
·
6 min read
Biotech Beach

Ventegra Announces the Successful Implementation of the New Ventegra Specialty Inclusion (VSI) Program

Ventegra, Inc. announced the successful implementation of the Ventegra Specialty Inclusion program to maintain broad access for payors, providers, and members to beneficial medications at an affordable cost.

May 1, 2024
·
3 min read
Policy

PBS Biotech Earns ISO 9001:2015 Certification, Demonstrating Commitment to Quality

PBS Biotech, a leading provider of single-use bioreactor systems and process development services, announces the successful attainment of the ISO 9001:2015 certification of its Quality Management System.

May 1, 2024
·
2 min read
MolecuLight Featured in 11 Presentations and Posters at European Wound Management Association (EWMA) 2024 Annual Conference

MolecuLight Inc. announces that its MolecuLight wound imaging platform is being prominently featured in several presentations and posters at the European Wound Management Association 2024 Annual Conference, being held from May 1 - 3, 2024 in London, United Kingdom.

May 1, 2024
·
6 min read
Business

Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion

Epsilogen, a global leader in the development of immunoglobulin E antibodies to treat cancer, announces the appointments of Ashley Nagle as Chief Business Officer and Peter Finan, currently a Non-Executive Director, as Non-Executive Chairman.

May 1, 2024
·
5 min read
Business

Tessellate BIO Announces Appointment of Professor Sandra Strauss to Scientific Advisory Board

Tessellate BIO announces the appointment of Professor Sandra Strauss, University College London, to its Scientific Advisory Board.

May 1, 2024
·
4 min read